IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 63 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,000 | -25.0% | 2,200 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $4,000 | -20.0% | 2,200 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $5,000 | -16.7% | 2,200 | -18.5% | 0.00% | 0.0% |
Q3 2017 | $6,000 | +20.0% | 2,700 | -6.9% | 0.00% | 0.0% |
Q2 2017 | $5,000 | -28.6% | 2,900 | +7.4% | 0.00% | 0.0% |
Q1 2017 | $7,000 | 0.0% | 2,700 | -40.3% | 0.00% | -50.0% |
Q4 2016 | $7,000 | -41.7% | 4,525 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $12,000 | +20.0% | 4,525 | -28.7% | 0.00% | 0.0% |
Q2 2016 | $10,000 | +100.0% | 6,350 | +130.9% | 0.00% | +50.0% |
Q1 2016 | $5,000 | -28.6% | 2,750 | +37.5% | 0.00% | -33.3% |
Q2 2015 | $7,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $7,000 | -22.2% | 2,000 | 0.0% | 0.00% | -25.0% |
Q4 2014 | $9,000 | +80.0% | 2,000 | 0.0% | 0.00% | +100.0% |
Q3 2014 | $5,000 | -58.3% | 2,000 | -52.9% | 0.00% | -66.7% |
Q2 2014 | $12,000 | – | 4,250 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 474,609 | $626,000 | 0.55% |
Kassirer Asset Management Corp | 325,800 | $430,000 | 0.28% |
CORRADO ADVISORS, LLC | 104,850 | $138,000 | 0.08% |
Artal Group S.A. | 2,750,000 | $3,630,000 | 0.08% |
ROPES WEALTH ADVISORS LLC | 100,000 | $132,000 | 0.04% |
MYCIO WEALTH PARTNERS, LLC | 246,527 | $325,000 | 0.03% |
Palo Alto Investors LP | 616,355 | $814,000 | 0.03% |
HOLLENCREST CAPITAL MANAGEMENT | 172,570 | $228,000 | 0.03% |
LAU ASSOCIATES LLC | 26,713 | $35,000 | 0.02% |
NATIXIS | 3,438,529 | $4,539,000 | 0.02% |